The impact of urate-lowering therapy on kidney function (IMPULsKF)
The concept of trial launched in Ukraine in 2017 with POEM design and 36-months duration is presented. It aims to investigate the impact of two target levels of urate-lowering therapy caused by hyperuricemia on kidney function and chronic kidney disease (CKD) progression measured by estimated glomer...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House Zaslavsky
2017-04-01
|
| Series: | Počki |
| Subjects: | |
| Online Access: | http://kidneys.zaslavsky.com.ua/article/view/102786 |